Interpace Diagnostics Group, Inc. Contracts & Agreements

Exchange Agreement, dated as of October 10, 2024, by and among Interpace Biosciences, Inc., 1315 Capital II, L.P. and Ampersand 2018 Limited Partnership (Filed With SEC on October 15, 2024)

Amended and Restated Investor Rights Agreement, dated as of October 10, 2024, by and among Interpace Biosciences, Inc., 1315 Capital II, L.P. and Ampersand 2018 Limited Partnership (Filed With SEC on October 15, 2024)

Termination of Support Agreement, dated as of October 14, 2024, by and between Interpace Biosciences, Inc. and 1315 Capital II, L.P (Filed With SEC on October 15, 2024)

Third Amendment to Loan and Security Agreement by and between BroadOak Fund V, L.P., Interpace Biosciences, Inc., Interpace Diagnostics Corporation, Interpace Diagnostics, LLC and... (Filed With SEC on April 1, 2024)

Second Amendment to Loan and Security Agreement and Waiver, dated April 22, 2022, by and among Interpace Biosciences, Inc., Interpace Diagnostics Corporation, Interpace... (Filed With SEC on November 8, 2023)

Third Amendment to Loan and Security Agreement and Waiver, dated June 13, 2022, by and among Interpace Biosciences, Inc., Interpace Diagnostics Corporation, Interpace Diagnostics,... (Filed With SEC on November 8, 2023)

Fourth Amendment to Loan and Security Agreement and Waiver, dated October 31, 2022, by and among Interpace Biosciences, Inc., Interpace Diagnostics Corporation, Interpace... (Filed With SEC on November 8, 2023)

Fifth Amendment to Loan and Security Agreement and Waiver, dated October 6, 2023, by and among Interpace Biosciences, Inc., Interpace Diagnostics Corporation, Interpace... (Filed With SEC on November 8, 2023)

Employment Agreement, dated July 31, 2023, between Christopher McCarthy and Interpace Biosciences, Inc (Filed With SEC on August 2, 2023)

Amendment to the Interpace Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on November 15, 2022)

Amendment to the Interpace Biosciences, Inc. Employee Stock Purchase Plan (Filed With SEC on November 15, 2022)

Fourth Lease Amendment (the Amendment) by and between Interpace Biosciences, Inc. and Saddle Lane Realty, LLC, dated as of October 31, 2022 (Filed With SEC on November 4, 2022)

Severance and Consulting Agreement and General Release, dated September 30, 2022, by and between Interpace Biosciences, Inc. and Thomas Freeburg (Filed With SEC on October 4, 2022)

Asset Purchase Agreement, dated August 31, 2022 by and among Interpace Biosciences, Inc., Interpace Pharma Solutions, Inc. and Flagship Biosciences, Inc (Filed With SEC on September 7, 2022)

Shared Services Agreement, dated August 31, 2022 by and among Interpace Biosciences, Inc., Interpace Pharma Solutions, Inc. and Flagship Biosciences, Inc (Filed With SEC on September 7, 2022)

Robert Gorman Letter Agreement dated April 16, 2020 (Filed With SEC on August 15, 2022)

Subordinated Convertible Promissory Note to BroadOak Fund V, L.P., dated May 5, 2022 (Filed With SEC on May 10, 2022)

Consent Letter between Comerica Bank and Interpace Biosciences, Inc., Interpace Diagnostics Corporation, Interpace Diagnostics, LLC, and Interpace Pharma Solutions, Inc. dated May... (Filed With SEC on May 10, 2022)

First Amendment to Loan and Security Agreement and Consent with BroadOak Fund V, L.P. dated May 5, 2022 between Interpace Biosciences, Inc., Interpace Diagnostics Corporation,... (Filed With SEC on May 10, 2022)

First Amendment to Subordination and Intercreditor Agreement by and between Comerica Bank, BroadOak Fund V, L.P., Interpace Biosciences, Inc., Interpace Diagnostics Corporation,... (Filed With SEC on May 10, 2022)

Agreement, dated January 21, 2022, between Dr. Vijay Aggarwal and Interpace Biosciences, Inc (Filed With SEC on January 27, 2022)

Form of Subscription Rights Certificate (Filed With SEC on January 3, 2022)

Form of Standby Purchase Agreement by and among Interpace Biosciences, Inc., 3K Limited Partnership, Peter H. Kamin, Peter H. Kamin Revocable Trust dated February 2003, Peter H.... (Filed With SEC on January 3, 2022)

Form of Registration Rights Agreement by and between Interpace Biosciences, Inc. and 3K Limited Partnership, to be entered into at the closing of the Standby Purchase Commitment (Filed With SEC on January 3, 2022)

Form of Investor Rights Agreement by and between Interpace Biosciences, Inc. and 3K Limited Partnership, to be entered into at the closing of the Standby Purchase Commitment (Filed With SEC on January 3, 2022)

Loan and Security Agreement by and between BroadOak Fund V, L.P., Interpace Biosciences, Inc., Interpace Diagnostics Corporation, Interpace Diagnostics, LLC and Interpace Pharma... (Filed With SEC on November 3, 2021)

First Amendment to Loan and Security Agreement by and between Comerica Bank, Interpace Biosciences, Inc., Interpace Diagnostics Corporation, Interpace Diagnostics, LLC and... (Filed With SEC on November 3, 2021)

Subordination and Intercreditor Agreement by and between Comerica Bank, BroadOak Fund V, L.P., Interpace Biosciences, Inc., Interpace Diagnostics Corporation, Interpace... (Filed With SEC on November 3, 2021)

Loan and Security Agreement by and between Comerica Bank, Interpace Biosciences, Inc., Interpace Diagnostics Corporation, Interpace Diagnostics, LLC and Interpace Pharma... (Filed With SEC on October 19, 2021)

Subordination Agreement by and between Ampersand 2018 Limited Partnership, 1315 Capital II. L.P., Comerica Bank Interpace Biosciences, Inc., Interpace Diagnostics Corporation,... (Filed With SEC on October 19, 2021)

Amendment to Secured Promissory Note dated May 10, 2021 with Ampersand 2018 Limited Partnership (Filed With SEC on August 11, 2021)

Amendment to Secured Promissory Note dated May 10, 2021 with1315 Capital II, L.P (Filed With SEC on August 11, 2021)

Amendment to Security Agreement dated May 10, 2021 by and between Ampersand 2018 Limited Partnership and Interpace Biosciences, Inc (Filed With SEC on August 11, 2021)

Asset Purchase Agreement by and among the Company and Diamir Biosciences Corp. dated March 16, 2021, . Upon the request of the SEC, the Company agrees to furnish copies of the... (Filed With SEC on May 11, 2021)

Employment agreement entered into May 10, 2021, effective February 1, 2021, between Thomas Freeburg and the Company (Filed With SEC on May 11, 2021)

Promissory Note entered into between the Company and Ampersand 2018 Limited Partnership, dated January 7, 2021 (Filed With SEC on May 11, 2021)

Promissory Note entered into between the Company and 1315 Capital II, L.P, dated January 7, 2021 (Filed With SEC on May 11, 2021)

Security Agreement entered into between the Company and Ampersand 2018 Limited Partnership, dated January 7, 2021 (Filed With SEC on May 11, 2021)

Description of Securities (Filed With SEC on April 1, 2021)

Lease Termination Notice to Meadows Landmark, LLC for the Companys laboratory facility at Meadows Office Complex, 201 Route 17 North, Rutherford, New Jersey, effective March 31,... (Filed With SEC on April 1, 2021)

Severance Agreement and General Release, dated January 31, 2021, by and between the Company and Fred Knechtel (Filed With SEC on February 4, 2021)

Employment Agreement, dated November 23, 2020, between Thomas W. Burnell and Interpace Biosciences, Inc (Filed With SEC on November 25, 2020)

Separation and Consulting Agreement and General Release, dated November 23, 2020, between Jack E. Stover and Interpace Biosciences, Inc (Filed With SEC on November 25, 2020)

Joinder and Second Loan Modification Agreement, dated October 19, 2020, by and among the Company, Interpace Diagnostics Corporation, Interpace Diagnostics, LLC, Interpace Pharma... (Filed With SEC on October 23, 2020)

Support Agreement, dated April 7, 2020, by and between Ampersand 2018 Limited Partnership and Interpace Biosciences, Inc (Filed With SEC on October 19, 2020)

Support Agreement, dated April 2, 2020, by and between 1315 Capital II, L.P. and Interpace Biosciences, Inc (Filed With SEC on October 19, 2020)

Termination Agreement, dated July 9, 2020, by and between Ampersand 2018 Limited Partnership and Interpace Biosciences, Inc (Filed With SEC on October 19, 2020)

First Loan Modification Agreement, dated March 18, 2019, by and among Silicon Valley Bank, Interpace Diagnostics Group, Inc. (n/k/a Interpace Biosciences, Inc.), Interpace... (Filed With SEC on October 19, 2020)

Amendment to the Interpace Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on June 26, 2020)

Form of Interpace Biosciences, Inc. 2019 Equity Incentive Plan Restricted Stock Unit And Restricted Stock Unit Agreement (Filed With SEC on June 26, 2020)

Eleventh Amendment to Lease, effective as of June 1, 2020, by and between Southport Business Park Limited Partnership and Interpace Pharma Solutions, Inc (Filed With SEC on June 9, 2020)

Description of Securities (Filed With SEC on April 22, 2020)

Loan and Security Agreement, dated November 13, 2018, by and among Silicon Valley Bank, Interpace Diagnostics Group, Inc., Interpace Diagnostics Corporation, and Interpace... (Filed With SEC on April 22, 2020)

Amendment No. 8 to Lease, dated December 31, 2019, by and between WE 2 Church Street South LLC and Interpace Diagnostics Lab Inc (Filed With SEC on April 22, 2020)

First Amendment, dated September 26, 2017, by and between Saddle Lane Realty, LLC and Interpace Diagnostics Corporation (Filed With SEC on April 22, 2020)

Office Lease Agreement, dated October 9, 2007, by and between Meadows Office, L.L.C. and Cancer Genetics, Inc (Filed With SEC on April 22, 2020)

First Amendment to Lease, dated October 30, 2017, by and between Meadows Landmark LLC and Cancer Genetics, Inc (Filed With SEC on April 22, 2020)

Consent to Assignment, dated July 19, 2019, by and among Meadows Landmark LLC, Cancer Genetics, Inc., and Interpace BioPharma, Inc (Filed With SEC on April 22, 2020)

Lease Agreement, dated June 12, 2004, by and between Southport Business Park Limited Partnership and Gentris Corporation (Filed With SEC on April 22, 2020)

Letter Amendment, dated October 21, 2004, by and between Southport Business Park Limited Partnership and Gentris Corporation (Filed With SEC on April 22, 2020)

Second Amendment to Lease, dated June 17, 2005, by and between Southport Business Park Limited Partnership and Gentris Corporation (Filed With SEC on April 22, 2020)

Third Amendment to Lease, dated May 25, 2006, by and between Southport Business Park Limited Partnership and Gentris Corporation (Filed With SEC on April 22, 2020)

Fourth Amendment to Lease, dated December 20, 2007, by and between Southport Business Park Limited Partnership and Gentris Corporation (Filed With SEC on April 22, 2020)

Fifth Amendment to Lease, dated June 15, 2009, by and between Southport Business Park Limited Partnership and Gentris Corporation (Filed With SEC on April 22, 2020)

Sixth Amendment to Lease, dated June 3, 2010, by and between Southport Business Park Limited Partnership and Gentris Corporation (Filed With SEC on April 22, 2020)

Seventh Amendment to Lease, dated October 26, 2010, by and between Southport Business Park Limited Partnership and Gentris Corporation (Filed With SEC on April 22, 2020)

Eighth Amendment to Lease, dated July 27, 2011, by and between Southport Business Park Limited Partnership and Gentris Corporation (Filed With SEC on April 22, 2020)

Ninth Amendment to Lease, dated November 7, 2012, by and between Southport Business Park Limited Partnership and Gentris Corporation (Filed With SEC on April 22, 2020)

Tenth Amendment to Lease, dated July 15, 2014, by and among Southport Business Park Limited Partnership, Gentris Corporation, and Gentris, LLC (Filed With SEC on April 22, 2020)

Assignment of Lease, dated July 15, 2019, by and between Cancer Genetics, Inc. and Interpace BioPharma, Inc (Filed With SEC on April 22, 2020)

Guaranty of Lease, dated July 15, 2019, by and between Interpace Diagnostics Group, Inc. and Southport Business Park Limited Partnership (Filed With SEC on April 22, 2020)

Employment Agreement, dated as of January 29, 2020, by and between Interpace Biosciences, Inc. and Fred Knechtel (Filed With SEC on January 31, 2020)

Severance and Consulting Agreement and General Release, dated January 29, 2020, by and between Interpace Biosciences, Inc. and James Early (Filed With SEC on January 31, 2020)

First Amendment to Amended and Restated Employment Agreement, dated January 29, 2020, by and between Interpace Biosciences, Inc. and Jack E. Stover (Filed With SEC on January 31, 2020)

Amended and Restated Investor Rights Agreement, dated as of January 15, 2020, by and among Interpace Biosciences, Inc., 1315 Capital II, L.P. and Ampersand 2018 Limited Partnership (Filed With SEC on January 17, 2020)

Form of Indemnification Agreement by and between Interpace Biosciences, Inc. and Indemnitee (Filed With SEC on January 17, 2020)

Form of Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock (included as Exhibit A to the Securities Purchase and Exchange... (Filed With SEC on January 14, 2020)

Interpace Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on November 14, 2019)

Interpace Biosciences, Inc. Employee Stock Purchase Plan (Filed With SEC on November 14, 2019)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Interpace Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on November 14, 2019)

Form of Stock Option Grant Notice and Stock Option Agreement under the Interpace Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on November 14, 2019)

Equity Distribution Agreement, dated September 20, 2019, by and between Interpace Diagnostics Group, Inc. and Oppenheimer & Co. Inc (Filed With SEC on September 20, 2019)

Subordinated Seller Note of Interpace BioPharma, Inc., dated July 15, 2019, in favor of Cancer Genetics, Inc (Filed With SEC on July 19, 2019)

Transition Services Agreement, dated July 15, 2019, by and between Interpace BioPharma, Inc. and Cancer Genetics, Inc (Filed With SEC on July 19, 2019)

Securities Purchase Agreement, dated July 15, 2019, by and between Interpace Diagnostics Group, Inc. and Ampersand 2018 Limited Partnership (Filed With SEC on July 19, 2019)

Investor Rights Agreement, dated July 15, 2019, by and between Interpace Diagnostics Group, Inc. and Ampersand 2018 Limited Partnership (Filed With SEC on July 19, 2019)

Form of Voting Agreement (Filed With SEC on July 19, 2019)

Secured Creditor Asset Purchase Agreement, dated July 15, 2019, by and among Interpace BioPharma, Inc., Cancer Genetics, Inc., Interpace Diagnostics Group, Inc. and Partners for... (Filed With SEC on July 19, 2019)

Employment Separation Agreement between Interpace Diagnostics, LLC and Gregory Richard, effective as of March 25, 2015 (Filed With SEC on March 21, 2019)

Underwriting Agreement, dated as of January 25, 2019, by and between Interpace Diagnostics Group, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 29, 2019)

Form of Underwriter Common Stock Purchase Warrant (Filed With SEC on January 29, 2019)

Amended and Restated Employment Agreement, dated as of December 5, 2018, by and between Interpace Diagnostics Group, Inc. and Jack E. Stover (Filed With SEC on December 11, 2018)

Form of Restricted Stock Unit Agreement for Employees (Filed With SEC on May 15, 2018)

Form of Restricted Stock Unit Agreement for Directors (Filed With SEC on May 15, 2018)

Form of Non-Qualified Stock Option Agreement (Filed With SEC on May 15, 2018)

Form of Incentive Option Agreement (Filed With SEC on May 15, 2018)

Employment Agreement between Interpace Diagnostics Group, Inc. and James Early, effective as of March 16, 2018 (Filed With SEC on March 23, 2018)

Amendment No. 2 to Lease, dated March 15, 2018, between Saddle Lane Realty, LLC and Interpace Diagnostics Corporation (Filed With SEC on March 23, 2018)

Form of Additional Warrant (Filed With SEC on October 12, 2017)

Warrant Exercise Agreement, dated October 12, 2017, by and between Interpace Diagnostics Group, Inc. and certain Warrant Holders (Filed With SEC on October 12, 2017)

INTERPACEDIAGNOSTICS GROUP, INC. UNDERWRITINGAGREEMENT (Filed With SEC on June 21, 2017)

InterpaceDiagnostics Group, Inc. and AmericanStock Transfer & Trust Company, LLC, as WarrantAgent WarrantAgency Agreement Datedas of June 21, 2017 (Filed With SEC on June 21, 2017)

PREFUNDEDCOMMON STOCK PURCHASE WARRANT INTERPACEDIAGNOSTICS GROUP, INC. (Filed With SEC on June 21, 2017)

COMMONSTOCK PURCHASE WARRANT INTERPACEDIAGNOSTICS GROUP, INC. (Filed With SEC on June 21, 2017)

INTERPACEDIAGNOSTICS GROUP, INC. UNDERWRITINGAGREEMENT (Filed With SEC on June 13, 2017)

PREFUNDEDCOMMON STOCK PURCHASE WARRANT INTERPACEDIAGNOSTICS GROUP, INC. (Filed With SEC on June 13, 2017)

COMMONSTOCK PURCHASE WARRANT INTERPACEDIAGNOSTICS GROUP, INC. (Filed With SEC on June 13, 2017)

FORMOF UNDERWRITERS’ WARRANTS (Filed With SEC on June 13, 2017)

InterpaceDiagnostics Group, Inc. and AmericanStock Transfer & Trust Company, LLC, as WarrantAgent WarrantAgency Agreement Datedas of June __, 2017 (Filed With SEC on June 13, 2017)

INTERPACE DIAGNOSTICS GROUP, INC. SENIOR SECURED CONVERTIBLE NOTE (Filed With SEC on April 18, 2017)

AMENDMENT AND EXCHANGE AGREEMENT (Filed With SEC on April 18, 2017)

Morris Corporate Center 1, Building A, 300 Interpace Parkway, Parsippany, New Jersey 07054 Phone: 862 ###-###-#### " Toll Free: 800 ###-###-#### " www.interpacediagnostics.com (Filed With SEC on April 3, 2017)

COMMON STOCK PURCHASE WARRANT INTERPACE DIAGNOSTICS GROUP, INC. (Filed With SEC on March 27, 2017)

AMENDED AND RESTATED SECURITY AND PLEDGE AGREEMENT (Filed With SEC on March 27, 2017)

AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on March 27, 2017)

AMENDED AND RESTATED GUARANTY (Filed With SEC on March 27, 2017)

Interpace Diagnostics Group, Inc. Senior Secured Note (Filed With SEC on March 23, 2017)

Interpace Diagnostics Group, Inc. Senior Secured Convertible Note (Filed With SEC on March 23, 2017)

COMMON STOCK PURCHASE WARRANT INTERPACE DIAGNOSTICS GROUP, INC. (Filed With SEC on March 23, 2017)

EXCHANGE AGREEMENT (Filed With SEC on March 23, 2017)

TERMINATION AGREEMENT (Filed With SEC on March 23, 2017)

UNDERWRITING AGREEMENT (Filed With SEC on February 3, 2017)

COMMON STOCK PURCHASE WARRANT INTERPACE DIAGNOSTICS GROUP, INC. (Filed With SEC on January 20, 2017)

[The remainder of this page has been intentionally left blank.] (Filed With SEC on January 20, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 20, 2017)

[The remainder of this page has been intentionally left blank.] (Filed With SEC on January 5, 2017)

AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 5, 2017)

PREPAID COMMON STOCK PURCHASE WARRANT INTERPACE DIAGNOSTICS GROUP, inc. (Filed With SEC on January 3, 2017)

[The remainder of this page has been intentionally left blank.] (Filed With SEC on January 3, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 3, 2017)

PREPAID COMMON STOCK PURCHASE WARRANT INTERPACE DIAGNOSTICS GROUP, inc. (Filed With SEC on December 19, 2016)

[The remainder of this page has been intentionally left blank.] (Filed With SEC on December 19, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 19, 2016)

FIFTH AMENDMENT TO NON-NEGOTIABLE SUBORDINATED SECURED PROMISSORY NOTE (Filed With SEC on November 17, 2016)

FOURTH AMENDMENT TO NON-NEGOTIABLE SUBORDINATED SECURED PROMISSORY NOTE (Filed With SEC on November 3, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on November 3, 2016)

INCENTIVE STOCK OPTION AGREEMENT UNDER THE AMENDED AND RESTATED 2004 STOCK AWARD AND INCENTIVE PLAN (Filed With SEC on October 20, 2016)

FORM OF INCENTIVE STOCK OPTION AGREEMENT UNDER THE AMENDED AND RESTATED 2004 STOCK AWARD AND INCENTIVE PLAN (Filed With SEC on October 20, 2016)

MANAGEMENT ENGAGEMENT LETTER (Filed With SEC on October 14, 2016)

CREDIT AND SECURITY AGREEMENT by and among INTERPACE DIAGNOSTICS GROUP, INC., INTERPACE DIAGNOSTICS CORPORATION, INTERPACE DIAGNOSTICS, LLC AND ANY ADDITIONAL ENTITY THAT MAY... (Filed With SEC on October 4, 2016)

INTERCREDITOR AGREEMENT (Filed With SEC on October 4, 2016)

THIRD AMENDMENT TO NON-NEGOTIABLE SUBORDINATED SECURED PROMISSORY NOTE (Filed With SEC on October 4, 2016)

INTERPACE DIAGNOSTICS GROUP, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on August 8, 2016)

EMPLOYMENT SEPARATION AGREEMENT (Filed With SEC on June 22, 2016)

CONFIDENTIAL INFORMATION, NON-DISCLOSURE, non-solicitation, NON-COMPETE, and RIGHTS TO INTELLECTUAL PROPERTY AGREEMENT (Filed With SEC on June 22, 2016)

SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on March 29, 2016)

AGREEMENT AND GENERAL RELEASE (Filed With SEC on January 22, 2016)

AGREEMENT AND GENERAL RELEASE (Filed With SEC on January 11, 2016)

PDI, Inc. Amended and Restated 2004 Stock Award and Incentive Plan (Filed With SEC on December 23, 2015)

AMENDMENT AGREEMENT (Filed With SEC on December 8, 2015)

AMENDMENT NO. 1 TO NOTE (Filed With SEC on November 12, 2015)

PDI, INC. Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 2, 2015)

LIMITED WAIVER, CONSENT AND AMENDMENT NO. 2 TO NOTE (Filed With SEC on November 2, 2015)

ASSET PURCHASE AGREEMENT by and between PUBLICIS TOUCHPOINT SOLUTIONS, INC., and PDI, INC. Dated October 30, 2015 (Filed With SEC on November 2, 2015)

SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on May 12, 2015)

ASSET PURCHASE AGREEMENT by and between ASURAGEN, INC. and INTERPACE DIAGNOSTICS, LLC Dated as of August 13, 2014 TABLE OF CONTENTS (Filed With SEC on November 5, 2014)

TRANSITION SERVICES AGREEMENT (Filed With SEC on November 5, 2014)

LICENSE AGREEMENT by and between Asuragen, Inc. and Interpace Diagnostics, LLC (Filed With SEC on November 5, 2014)

LICENSE AGREEMENT By and between Asuragen, Inc. and Interpace Diagnostics, LLC (Filed With SEC on November 5, 2014)

SUPPLY AGREEMENT by and between Asuragen, Inc. and Interpace Diagnostics, LLC Dated as of August 13, 2014 TABLE OF CONTENTS (Filed With SEC on November 5, 2014)

GUARANTY of PDI, INC. (Filed With SEC on November 5, 2014)

Portions of this exhibit were omitted and filed separately with the Secretary of the Securities and Exchange Commission pursuant to an application for confidential treatment filed... (Filed With SEC on November 5, 2014)

Morris Corporate Center 1, 300 Interpace Parkway, Parsippany, New Jersey 07054 Phone: 862 ###-###-#### Toll Free: 800 ###-###-#### www.pdi-inc.com (Filed With SEC on October 20, 2014)

EMPLOYMENT SEPARATION AGREEMENT (Filed With SEC on October 20, 2014)

FORM OF PDI, INC. 2004 STOCK AWARD AND INCENTIVE PLAN RESTRICTED STOCK UNIT INDUCEMENT AGREEMENT (Filed With SEC on October 20, 2014)

FORM OF PDI, INC. STOCK APPRECIATION RIGHTS (SARs) INDUCEMENT AGREEMENT FOR Graham Miao October 20, 2014 (Filed With SEC on October 20, 2014)

PDI, INC. 2004 STOCK AWARD AND INCENTIVE PLAN STOCK APPRECIATION RIGHTS AGREEMENT (Filed With SEC on March 6, 2014)

Portions of this exhibit were omitted and filed separately with the Secretary of the Securities and Exchange Commission pursuant to an application for confidential treatment filed... (Filed With SEC on November 13, 2013)

Portions of this exhibit were omitted and filed separately with the Secretary of the Securities and Exchange Commission pursuant to an application for confidential treatment filed... (Filed With SEC on March 15, 2013)

AMENDMENT NO. 1 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT (Filed With SEC on March 15, 2013)

ASSET PURCHASE AGREEMENT (Filed With SEC on March 9, 2012)

AMENDMENT NO. 1 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT (Filed With SEC on March 6, 2012)

ASSET PURCHASE AGREEMENT (Filed With SEC on December 30, 2011)

AMENDMENT TO MEMBERSHIP INTEREST PURCHASE AGREEMENT (Filed With SEC on November 21, 2011)

RETIREMENT AGREEMENT AND GENERAL RELEASE (Filed With SEC on November 21, 2011)

FIRST AMENDMENT TO SUBLEASE (Filed With SEC on November 10, 2011)

AMENDMENT No. 1 to STOCK APPRECIATION RIGHTS AGREEMENT for Nancy Lurker (Filed With SEC on May 6, 2011)

AMENDMENT No. 1 to STOCK APPRECIATION RIGHTS AGREEMENT for David E. Kerr (Filed With SEC on May 6, 2011)

INDEMNIFICATION AGREEMENT (Filed With SEC on April 20, 2011)

MEMBERSHIP INTEREST PURCHASE AGREEMENT BY AND AMONG GROUP DCA, LLC, JD & RL, INC., ROBERT O. LIKOFF, JACK DAVIS, THE SELLER REPRESENTATIVE AND PDI, INC. November 3, 2010 (Filed With SEC on March 23, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on March 23, 2011)

AGREEMENT OF LEASE between PRINCIPAL PROPERTIES, L.P. and GROUP DCA, INC. Complex: 800 Lanidex Plaza Parsippany, NJ 07054 (Filed With SEC on March 23, 2011)

PDI, INC. 2004 STOCK AWARD AND INCENTIVE PLAN STOCK APPRECIATION RIGHTS AGREEMENT (Filed With SEC on March 23, 2011)

PDI, Inc. Term Sheet - New Hire Chief Executive Officer (Filed With SEC on March 23, 2011)

FIRST AMENDMENT TO SUBLEASE (Filed With SEC on December 4, 2009)

LEASE AGREEMENT BETWEEN OTR-MCC LLC LANDLORD AND PDI, INC. TENANT DATED AS OF NOVEMBER 3, 2009 POD A MORRIS CORPORATE CENTER PARSIPPANY, NEW JERSEY (Filed With SEC on November 5, 2009)

EMPLOYMENT SEPARATIONAGREEMENT (Filed With SEC on April 7, 2009)

AMENDED AND RESTATEDEMPLOYMENT SEPARATION AGREEMENT (Filed With SEC on April 7, 2009)

PDI,INC. 2004STOCK AWARD AND INCENTIVE PLAN RESTRICTEDSTOCK UNIT AGREEMENT (Filed With SEC on March 13, 2009)

PDI,INC. 2004STOCK AWARD AND INCENTIVE PLAN STOCKAPPRECIATION RIGHTS AGREEMENT (Filed With SEC on March 13, 2009)

PDI,INC. 2004STOCK AWARD AND INCENTIVE PLAN RESTRICTEDSTOCK UNIT AGREEMENT (Filed With SEC on March 13, 2009)

AMENDED AND RESTATEDEMPLOYMENT SEPARATION AGREEMENT (Filed With SEC on January 7, 2009)

EMPLOYMENT SEPARATIONAGREEMENT (Filed With SEC on November 18, 2008)

EMPLOYMENT SEPARATIONAGREEMENT (Filed With SEC on May 9, 2008)

SUBLEASE (Filed With SEC on March 13, 2008)

EMPLOYMENT SEPARATION AGREEMENT (Filed With SEC on March 16, 2007)

EMPLOYMENT SEPARATION AGREEMENT (Filed With SEC on August 9, 2006)

AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 9, 2006)

BASE COMPENSATION (Filed With SEC on March 17, 2006)

MEMORANDUM OF UNDERSTANDING (Filed With SEC on March 17, 2006)

AMENDMENT TO MEMORANDUM OF UNDERSTANDING (Filed With SEC on March 17, 2006)

SUBLEASE (Filed With SEC on March 17, 2006)

Category

Industry

Companies

Contracts

Interpace Diagnostics Group, Inc. Contracts & Agreements